R-d Hofheinz
Mannheim, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Reassessing the role of CEA in the treatment of rectal cancer in the era of TNT.
Journal: ESMO gastrointestinal oncology
Published: August 12, 2026
Chemotherapy for patients with circulating tumour DNA-positive, stage II colon cancer (CIRCULATE)-an AIO/ABCSG trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 20, 2026
Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 25, 2025
Chemotherapy before or after preoperative chemoradiotherapy and surgery for locally advanced rectal cancer: 5-year results of the CAO/ARO/AIO-12 trial - a general pairwise comparison.
Journal: ESMO open
Published: December 18, 2024
Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 17, 2019
Letter to the editors of the Journal of Cancer Research and Clinical Oncology.
Journal: Journal of cancer research and clinical oncology
Published: March 20, 2019
Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 12, 2018
Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 03, 2018
Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials.
Journal: Gastroenterology research and practice
Published: March 14, 2016
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 19, 2015
Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials.
Journal: Gastroenterology research and practice
Published: December 15, 2014
The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 11, 2014
Last Updated: 09/26/2026